Lin C - Search Results

1

Metformin sensitizes EGFR-TKI-resistant human lung cancer cells in vitro and in vivo through inhibition of IL-6 signaling and EMT reversal.

Li L, Han R, Xiao H, Lin C, Wang Y, Liu H, Li K, Chen H, Sun F, Yang Z, Jiang J, He Y. Li L, et al. Among authors: lin c. Clin Cancer Res. 2014 May 15;20(10):2714-26. doi: 10.1158/1078-0432.CCR-13-2613. Epub 2014 Mar 18. Clin Cancer Res. 2014. PMID: 24644001

2

Metformin attenuates gefitinib-induced exacerbation of pulmonary fibrosis by inhibition of TGF-β signaling pathway.

Li L, Huang W, Li K, Zhang K, Lin C, Han R, Lu C, Wang Y, Chen H, Sun F, He Y. Li L, et al. Among authors: lin c. Oncotarget. 2015 Dec 22;6(41):43605-19. doi: 10.18632/oncotarget.6186. Oncotarget. 2015. PMID: 26497205 Free PMC article.

3

Metformin restores crizotinib sensitivity in crizotinib-resistant human lung cancer cells through inhibition of IGF1-R signaling pathway.

Li L, Wang Y, Peng T, Zhang K, Lin C, Han R, Lu C, He Y. Li L, et al. Among authors: lin c. Oncotarget. 2016 Jun 7;7(23):34442-52. doi: 10.18632/oncotarget.9120. Oncotarget. 2016. PMID: 27144340 Free PMC article.

4

Vorinostat and metformin sensitize EGFR-TKI resistant NSCLC cells via BIM-dependent apoptosis induction.

Chen H, Wang Y, Lin C, Lu C, Han R, Jiao L, Li L, He Y. Chen H, et al. Among authors: lin c. Oncotarget. 2017 Sep 23;8(55):93825-93838. doi: 10.18632/oncotarget.21225. eCollection 2017 Nov 7. Oncotarget. 2017. PMID: 29212192 Free PMC article.

5

Caveolin-1-mediated STAT3 activation determines electrotaxis of human lung cancer cells.

Li L, Zhang K, Lu C, Sun Q, Zhao S, Jiao L, Han R, Lin C, Jiang J, Zhao M, He Y. Li L, et al. Among authors: lin c. Oncotarget. 2017 Sep 28;8(56):95741-95754. doi: 10.18632/oncotarget.21306. eCollection 2017 Nov 10. Oncotarget. 2017. PMID: 29221162 Free PMC article.

6

Correction: Caveolin-1-mediated STAT3 activation determines electrotaxis of human lung cancer cells.

Li L, Zhang K, Lu C, Sun Q, Zhao S, Jiao L, Han R, Lin C, Jiang J, Zhao M, He Y. Li L, et al. Among authors: lin c. Oncotarget. 2018 Jun 15;9(46):28291. doi: 10.18632/oncotarget.25675. eCollection 2018 Jun 15. Oncotarget. 2018. PMID: 29963279 Free PMC article.

7

Combined treatment with metformin and gefitinib overcomes primary resistance to EGFR-TKIs with EGFR mutation via targeting IGF-1R signaling pathway.

Pan YH, Jiao L, Lin CY, Lu CH, Li L, Chen HY, Wang YB, He Y. Pan YH, et al. Biologics. 2018 Aug 20;12:75-86. doi: 10.2147/BTT.S166867. eCollection 2018. Biologics. 2018. PMID: 30154647 Free PMC article.

8

Metformin synergistically enhances the antitumor activity of the third-generation EGFR-TKI CO-1686 in lung cancer cells through suppressing NF-κB signaling.

Pan YH, Lin CY, Lu CH, Li L, Wang YB, Chen HY, He Y. Pan YH, et al. Clin Respir J. 2018 Dec;12(12):2642-2652. doi: 10.1111/crj.12970. Epub 2018 Nov 9. Clin Respir J. 2018. PMID: 30307719

9

Protective autophagy decreases osimertinib cytotoxicity through regulation of stem cell-like properties in lung cancer.

Li L, Wang Y, Jiao L, Lin C, Lu C, Zhang K, Hu C, Ye J, Zhang D, Wu H, Feng M, He Y. Li L, et al. Among authors: lin c. Cancer Lett. 2019 Jun 28;452:191-202. doi: 10.1016/j.canlet.2019.03.027. Epub 2019 Mar 22. Cancer Lett. 2019. PMID: 30910592

10

Applied electric fields suppress osimertinib-induced cytotoxicity via inhibiting FOXO3a nuclear translocation through AKT activation.

Li L, Hu C, Lu C, Zhang K, Han R, Lin C, Zhao S, A C, Cheng C, Zhao M, He Y. Li L, et al. Among authors: lin c. Carcinogenesis. 2020 Jul 10;41(5):600-610. doi: 10.1093/carcin/bgz150. Carcinogenesis. 2020. PMID: 31504249

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

45,585 results

Search Page

Filters